Table of Contents

company-logo

Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of medicines in the areas of oncology and infectious diseases. The company's lead program is Endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It is also developing AT-H201, an inhalation therapy to improve lung function in severely ill and hospitalized COVID-19 patients; AT-301, a proprietary drug candidate for nasal administration in patients diagnosed with COVID-19; and immunotherapy/chimeric antigen receptor therapy programs for the treatment of breast cancer. It has a research agreement with Dana-Farber Cancer Institute, Inc. to support research of cytokine-coated nanoparticles for the treatment of breast cancer. The company was formerly known as Atossa Genetics Inc. and changed its name to Atossa Therapeutics, Inc. in January 2020. Atossa Therapeutics, Inc. was founded in 2008 and is headquartered in Seattle, Washington.

Atossa Therapeutics Dividend Announcement

• Atossa Therapeutics does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Atossa Therapeutics dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Atossa Therapeutics Dividend History

Atossa Therapeutics Dividend Yield

Atossa Therapeutics current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Atossa Therapeutics stock? Use our calculator to estimate your expected dividend yield:

Atossa Therapeutics Financial Ratios

P/E ratio-5.84
PEG ratio-0.06
P/B ratio2.13
ROE-32.56%
Payout ratio0.00%
Current ratio13.30
Quick ratio13.30
Cash Ratio12.90

Atossa Therapeutics Dividend FAQ

Does Atossa Therapeutics stock pay dividends?
Atossa Therapeutics does not currently pay dividends to its shareholders.
Has Atossa Therapeutics ever paid a dividend?
No, Atossa Therapeutics has no a history of paying dividends to its shareholders. Atossa Therapeutics is not known for its dividend payments.
Why doesn't Atossa Therapeutics pay dividends?
There are several potential reasons why Atossa Therapeutics would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Atossa Therapeutics ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Atossa Therapeutics has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Atossa Therapeutics a dividend aristocrat?
Atossa Therapeutics is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Atossa Therapeutics a dividend king?
Atossa Therapeutics is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Atossa Therapeutics a dividend stock?
No, Atossa Therapeutics is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Atossa Therapeutics stocks?
To buy Atossa Therapeutics you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Atossa Therapeutics stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.